Eli Lilly aims to acquire Versanis Bio after Reps were investing in LLY
Eli Lilly said it would acquire Versanis Bio, a private company developing a treatment for obesity on.wsj.com/3rswOrR
Related Reading
- 2 days ago
Lawmakers Move as Trump’s Crypto Agenda Takes Shape
- 2025-06-19
Politician Trades & The Defense Rally: Profiting Off War?
- 2025-05-05
The Billion-Dollar Game: How Congress Trade the Market It Governs
- 2025-04-09
Trump’s Tariff Triggered Turmoil: The Economic & Market Fallout
- 2025-02-28
Rep. Khanna introduces Drain the Swamp Act to curb lobbyist influence